In a 60-year-old patient with hyponatremia (serum sodium 132 mmol/L), should trazodone 100 mg nightly be restarted?

Do Not Restart Trazodone with Sodium of 132 mmol/L

You should not restart trazodone 100 mg nightly in this 60-year-old patient with a serum sodium of 132 mmol/L, as trazodone is a known cause of hyponatremia through SIADH and can worsen the existing electrolyte abnormality, potentially leading to serious neurological complications.

Rationale Based on FDA Drug Label

The FDA label for trazodone explicitly warns that hyponatremia may occur as a result of treatment with trazodone, with cases reported as low as serum sodium <110 mmol/L 1. The mechanism is typically SIADH (syndrome of inappropriate antidiuretic hormone secretion). The label specifically states: "In patients with symptomatic hyponatremia, discontinue Trazodone Hydrochloride Tablets and institute appropriate medical intervention" 1.

Critically, elderly patients (and this patient is 60 years old) are at greater risk of developing hyponatremia with serotonergic agents like trazodone 1.

Clinical Context of Current Sodium Level

Your patient's sodium of 132 mmol/L represents mild hyponatremia (normal range 135-145 mmol/L). While neurosurgical guidelines suggest investigating and treating hyponatremia when sodium falls below 131 mmol/L 2, this patient is only 1 mmol/L above this threshold. Restarting a medication known to cause hyponatremia in a patient already borderline hyponatremic is clinically inappropriate and potentially dangerous.

Recent large cohort data confirms that SSRIs and serotonergic agents like trazodone significantly increase hyponatremia risk, particularly in patients ≥60 years 3. One case report documented fatal cerebral edema, seizures, and severe hyponatremia from trazodone overdose via SIADH mechanism 4.

Management Algorithm

Before considering trazodone restart:

1. Identify and correct the cause of current hyponatremia - Determine if hypovolemic, euvolemic, or hypervolemic
2. Achieve stable sodium ≥135 mmol/L - Use appropriate treatment based on volume status (fluid restriction for SIADH, volume repletion for hypovolemia, etc.) 5, 6
3. Reassess the necessity of trazodone - Consider alternative agents for insomnia/depression that carry lower hyponatremia risk
4. If trazodone is absolutely necessary - Only restart after sodium normalizes AND with:
   • Close monitoring (check sodium within 3-7 days of restart, then weekly for first month)
   • Patient education about hyponatremia symptoms (headache, confusion, weakness, nausea)
   • Lower starting dose consideration

Common Pitfalls to Avoid

• Do not assume the current hyponatremia is unrelated to prior trazodone use - If the patient was recently on trazodone, it may be the culprit
• Do not restart without correcting sodium first - Starting at 132 mmol/L risks progression to symptomatic hyponatremia (<130 mmol/L)
• Do not ignore age as a risk factor - At 60 years old, this patient has increased vulnerability to drug-induced hyponatremia 1, 3
• Do not restart without a monitoring plan - Trazodone-induced hyponatremia can develop insidiously

Alternative Considerations

If the indication is insomnia, consider non-serotonergic alternatives with lower hyponatremia risk. If the indication is depression, other antidepressants may be considered, though note that SSRIs also carry hyponatremia risk 3, 7.

The risk-benefit analysis clearly favors not restarting trazodone until sodium normalizes and the underlying cause is addressed, given the FDA warning, the patient's age, and current borderline hyponatremia.